Antiviral Pills
- All
- News
- Videos
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
New York City To Deliver Free Antiviral Pills To Covid Patients
New York City will provide free antiviral pills, home-delivered, to people who test positive and are at higher risk from Covid-19, Mayor Eric Adams announced on Sunday.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
Pfizer Covid Pill Nearly 90% Effective, Works On Omicron, Shows Lab Data
Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast
-
Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
The Era Of Anti-Covid Pills: What You Need To Know
US pharma giants Merck and Pfizer have announced encouraging results for oral aniviral pills, in what could open up a new chapter in the fight against the COVID-19 pandemic.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
WHO "Strongly Recommends" Pfizer's Antiviral Covid pill
The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
New York City To Deliver Free Antiviral Pills To Covid Patients
New York City will provide free antiviral pills, home-delivered, to people who test positive and are at higher risk from Covid-19, Mayor Eric Adams announced on Sunday.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
South Korea To Deploy Pfizer COVID-19 Pills As Omicron Wave Looms
South Korea will begin treating coronavirus patients with Pfizer's antiviral pills on Friday, health officials said, as concern mounts over the spread of the highly contagious Omicron variant.
-
Joe Biden Doubles US Purchase Of Pfizer Covid Pills As Cases Surge
President Joe Biden announced Tuesday a doubling of US government purchases of new Pfizer therapeutic pills designed to combat the worst effects of Covid-19.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
South Korea Authorises Emergency Use Of Pfizer's Antiviral Covid Pill
South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety.
-
Pfizer Covid Pill Nearly 90% Effective, Works On Omicron, Shows Lab Data
Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast
-
Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its oral antiviral Covid-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
The Era Of Anti-Covid Pills: What You Need To Know
US pharma giants Merck and Pfizer have announced encouraging results for oral aniviral pills, in what could open up a new chapter in the fight against the COVID-19 pandemic.
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
